Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

18.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphorothioate-Free and Self-Interaction-Reduced Acyclic Nucleic Acids for Effective Antisense Oligonucleotide.

Journal of medicinal chemistry·2026
Same author

Formulation-Driven Control of mRNA Polyplex Physicochemical Properties Enables Spleen-Targeted Systemic Delivery.

ACS applied bio materials·2026
Same author

Delivery of Circular RNAs into Splenic Immune Cells via Intravenous Administration of Polyaspartamide Derivative Polyplexes.

ACS biomaterials science & engineering·2026
Same author

Heteroduplex oligonucleotide technology boosts gene knockdown in cardiac and skeletal muscles.

Nucleic acids research·2026
Same author

Preparation of Size-Defined PEG-Grafted Copolymers as a Polymeric Nanoruler for Size Optimization in Passive Targeting.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Enhanced Accumulation of Heteroduplex Oligonucleotides in Dystrophin-Deficient Skeletal Muscles by Single Oligonucleotide-Loaded Unit Polyion Complexes.

ACS omega·2025

Related Experiment Video

Updated: Mar 13, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.0K

Smart polymeric nanocarriers for small nucleic acid delivery.

Kanjiro Miyata1

  • 1Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo.

Drug Discoveries & Therapeutics
|October 18, 2016
PubMed
Summary

Nucleic acid therapeutics show promise but face delivery challenges. This review focuses on polymer carriers and responsive chemistry to improve systemic delivery and overcome biological barriers for these advanced medicines.

Area of Science:

  • Biomedical Engineering
  • Drug Delivery
  • Molecular Therapeutics

Background:

  • Nucleic acid therapeutics offer high target specificity for treating diseases.
  • Limited approved nucleic acid drugs are attributed to poor bioavailability.
  • Effective delivery carriers are essential for therapeutic success.

Purpose of the Study:

  • To review polymer-based delivery carriers for systemic administration of nucleic acids.
  • To highlight the role of biological environment-responsive chemistry in overcoming delivery barriers.
  • To discuss strategies for enhancing nucleic acid drug efficacy.

Main Methods:

  • Literature review of polymer-based nucleic acid delivery systems.
  • Analysis of biological barriers affecting systemic delivery.

More Related Videos

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

16.8K
Assembly and Characterization of Polyelectrolyte Complex Micelles
08:44

Assembly and Characterization of Polyelectrolyte Complex Micelles

Published on: March 2, 2020

11.6K

Related Experiment Videos

Last Updated: Mar 13, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

8.0K
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
08:51

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry

Published on: March 1, 2013

16.8K
Assembly and Characterization of Polyelectrolyte Complex Micelles
08:44

Assembly and Characterization of Polyelectrolyte Complex Micelles

Published on: March 2, 2020

11.6K
  • Exploration of responsive chemistry for targeted delivery.
  • Main Results:

    • Polymer carriers are a promising strategy for nucleic acid delivery.
    • Responsive chemistry can enhance carrier performance in biological environments.
    • Overcoming bioavailability issues is key to clinical translation.

    Conclusions:

    • Polymer-based carriers are crucial for advancing nucleic acid therapeutics.
    • Responsive materials offer innovative solutions for targeted drug delivery.
    • Further development is needed to translate these findings into approved therapies.